T. Mulvey

A Phase II Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma.

E. Winer, W. Barry, H. Rugo, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Response-guided neoadjuvant sacituzumab govitecan for localized triple negative breast cancer: results from the NeoSTAR trial.

L. Trippa, L. Ellisen, A. Comander, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.